China NMPA Product Recall - Magnetic Resonance Imaging System; Positron Emission Magnetic Resonance Imaging System

On September 23, 2020, GE Healthcare Systems Trading Development (Shanghai) Co., Ltd. initiated a voluntary Class II recall for its Magnetic Resonance Imaging (MRI) Systems and Positron Emission Magnetic Resonance Imaging Systems. This crucial action, overseen by the National Medical Products Administration (NMPA) and reported via the Shanghai Municipal Drug Administration Website, addresses a significant product safety concern. The primary issue identified involves the presence of sharp edges exposed inside the PGR cabinet within these medical devices. This design flaw creates a potential risk for internal cables to be damaged, which could subsequently lead to electrical malfunctions during the operation of the MRI systems. The regulatory framework under which this recall is executed emphasizes patient safety and product reliability, mandating that companies address such manufacturing deficiencies. The required actions involve the systematic recall of affected product models, specifications, and batches, with comprehensive details provided in the Medical Device Recall Event Report Form. This recall highlights the manufacturer's responsibility to identify and mitigate risks, ensuring that medical devices meet stringent safety standards.